Proteomic identification of haptoglobin as a stroke plasma biomarker in spontaneously hypertensive stroke-prone rats.
OBJECTIVE
We investigated changes in the expression of plasma proteins in spontaneously hypertensive stroke-prone rats (SHRSP) to identify stroke biomarkers.


RESULTS
The present analysis using surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) demonstrated that three peaks at mass/charge ratios (m/z) of 9330, 9480 and 9700 decreased in intensity during the development and progression of hypertensive stroke in SHRSPs, but not in age-matched control SHR and Wistar rats. Administration of verapamil, an L-type calcium channel blocker which was effective for hypertension in SHRSP rats, prevented the decrease in plasma protein expression. A candidate biomarker protein (m/z 9330) was identified using LC-MS/MS as haptoglobin (Hp). Immunoblotting with anti-Hp antibody demonstrated the decreased expression of both Hpalpha and Hpbeta chains in SHRSP. In contrast, haptoglobin mRNA expression in the liver of SHRSPs slightly increased as compared with control rats.


CONCLUSIONS
These findings suggest that Hp is a biomarker candidate for discriminating pathogenic alterations of stroke.
Kiga
Chizuru
C
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Sakurai
Hiroaki
H
Goto
Hirozo
H
Hayashi
Kazuko
K
Shimada
Yutaka
Y
Saiki
Ikuo
I
D000818:Animals; D015415:Biomarkers; D001798:Blood Proteins / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis*; D006973:Hypertension / Q000097:blood / Q000150:complications*; D008297:Male; D040901:Proteomics; D051381:Rats; D011918:Rats, Inbred SHR; D017208:Rats, Wistar; D020521:Stroke / Q000097:blood* / Q000175:diagnosis; D014700:Verapamil / Q000494:pharmacology; D015431:Weight Loss / Q000187:drug effects
D015415:Biomarkers; D001798:Blood Proteins; D006242:Haptoglobins; D014700:Verapamil